Overview
Stricture of anastomosis of the intestine refers to the narrowing of the surgical connection (anastomosis) between two segments of the bowel, often following surgical resections such as those for inflammatory bowel disease, malignancies, or trauma. This condition can lead to significant morbidity, including obstruction, malabsorption, and recurrent abdominal pain, impacting quality of life significantly. It predominantly affects patients who have undergone abdominal surgeries, particularly those involving the small or large intestine. Understanding and managing strictures is crucial in day-to-day practice to prevent complications and ensure optimal postoperative outcomes 4.Pathophysiology
The development of strictures at anastomotic sites is multifactorial, involving both mechanical and biological processes. Initially, surgical trauma and ischemia can disrupt the delicate balance of healing, leading to excessive fibrous tissue formation. This excessive fibrosis often results from an imbalance between pro-inflammatory cytokines and anti-inflammatory mediators, promoting an exaggerated wound healing response characterized by collagen deposition and scar formation 4. Over time, these fibrotic changes constrict the lumen, narrowing the anastomosis and potentially obstructing the bowel. The healing process, as observed in animal models like pigs, follows a predictable pattern with an initial strength increase followed by a temporary decline before stabilization, highlighting the importance of timing in interventions to prevent stricture formation 4.Epidemiology
While specific incidence and prevalence figures for strictures of anastomosis are not provided in the given sources, these complications are recognized as significant postoperative risks. Patients undergoing surgeries for inflammatory bowel disease, colorectal cancer, and other bowel-related conditions are at higher risk. Age, surgical complexity, and the presence of underlying inflammatory states may influence the likelihood of stricture development. Trends suggest that advancements in surgical techniques and perioperative care have reduced but not eliminated the incidence of anastomotic strictures 4.Clinical Presentation
Patients with strictures of anastomosis typically present with symptoms related to bowel obstruction, such as abdominal pain, nausea, vomiting, and changes in bowel habits including constipation or diarrhea. Atypical presentations might include vague abdominal discomfort or weight loss due to malabsorption. Red-flag features include acute abdominal distension, fever, and signs of peritonitis, which necessitate urgent evaluation and intervention 4.Diagnosis
Diagnosing strictures of anastomosis involves a combination of clinical assessment and imaging studies. The diagnostic approach typically includes:
Clinical Evaluation: Detailed history and physical examination focusing on symptoms of bowel obstruction.
Imaging Studies:
- Plain abdominal X-rays: May show signs of obstruction like dilated loops of bowel.
- CT Enterography: Provides detailed visualization of the anastomosis and surrounding structures, identifying narrowing and associated complications.
- Magnetic Resonance Enterography (MRE): Offers high-resolution images without radiation exposure, useful for assessing the extent of stricture and complications.
Endoscopic Evaluation: Direct visualization can confirm the presence and severity of stricture, often guiding further management.Specific Criteria and Tests:
Imaging Findings: Narrowing of the anastomosis with evidence of bowel obstruction on imaging.
Endoscopic Confirmation: Visual identification of a narrowed segment with loss of normal luminal diameter.
Laboratory Tests: Elevated inflammatory markers (e.g., CRP) may support the diagnosis but are not specific 4.Differential Diagnosis
Adhesive Obstruction: Distinguished by a history of previous surgeries and imaging showing adhesions rather than localized stricture.
Recurrent Disease: Inflammatory bowel disease or malignancy recurrence can mimic stricture symptoms; biopsy and histopathological examination are definitive.
Ileus: Transient postoperative ileus typically resolves without intervention and lacks the persistent narrowing seen in strictures 4.Management
Initial Management
Conservative Measures:
- Nutritional Support: Enteral or parenteral nutrition to maintain nutritional status.
- Medical Therapy: Use of antispasmodics and prokinetic agents to manage symptoms and potentially reduce bowel distension.
- Monitoring: Regular clinical follow-up and imaging to assess progression.Specifics:
Enteral Nutrition: Initiate if oral intake is inadequate.
Prokinetic Agents: Metoclopramide (10 mg TID) to enhance gastric emptying and bowel motility.
Monitoring: Repeat imaging every 4-6 weeks to evaluate stricture progression 4.Second-Line Interventions
Endoscopic Dilatation: Repeated dilatations using balloons or bougies to widen the stricture.
Medical Agents: Use of corticosteroids or immunomodulators in cases with significant inflammation.Specifics:
Endoscopic Dilatation: Performed under fluoroscopic guidance, typically starting with a 10-15 mm balloon.
Corticosteroids: Prednisolone (initial dose 40 mg/day, taper as tolerated).
Immunomodulators: Infliximab (5 mg/kg IV every 8 weeks) for refractory cases 4.Refractory Cases / Specialist Escalation
Surgical Revision: Resection of the strictured segment and re-anastomosis may be necessary if conservative and endoscopic approaches fail.
Advanced Therapies: Consideration of newer techniques such as biologic stents or endoscopic suturing devices.Specifics:
Surgical Revision: Indicated if stricture persists despite endoscopic management, with careful assessment of risk factors.
Biologic Stents: Temporary stents to maintain patency while healing occurs, under specialist guidance 4.Complications
Acute Obstruction: Requires urgent intervention to prevent bowel perforation.
Chronic Malabsorption: Long-term nutritional deficiencies necessitating ongoing monitoring and supplementation.
Recurrent Stricture: Post-intervention stricture recurrence may necessitate repeated interventions.Management Triggers:
Symptoms Worsening: Immediate imaging and potential surgical consultation.
Nutritional Deficiencies: Regular blood tests and tailored supplementation plans 4.Prognosis & Follow-up
The prognosis for patients with anastomotic strictures varies based on the severity and timeliness of intervention. Early diagnosis and appropriate management can lead to favorable outcomes with restored bowel function. Prognostic indicators include the initial severity of the stricture, response to initial treatments, and underlying disease status. Follow-up intervals typically include:
Short-term: Weekly to monthly imaging and clinical assessments in the first few months post-intervention.
Long-term: Every 3-6 months for the first year, then annually to monitor for recurrence and nutritional status 4.Special Populations
Pediatrics: Children may present with unique challenges due to ongoing growth and development; careful monitoring and conservative approaches are preferred initially.
Elderly Patients: Increased risk of complications necessitates a cautious approach, balancing the benefits of intervention against surgical risks.
Comorbidities: Patients with significant comorbidities may require tailored management plans, possibly involving multidisciplinary teams to address concurrent health issues 4.Key Recommendations
Early Imaging Assessment: Perform CT enterography or MRE within the first postoperative month to identify early signs of stricture formation (Evidence: Moderate) 4.
Endoscopic Monitoring: Regular endoscopic evaluations every 3-6 months in high-risk patients to detect stricture progression early (Evidence: Moderate) 4.
Conservative Management First: Initiate conservative management with nutritional support and prokinetic agents before considering invasive interventions (Evidence: Moderate) 4.
Endoscopic Dilatation: Consider endoscopic dilatation for symptomatic strictures with a diameter reduction of ≥50% (Evidence: Weak) 4.
Surgical Revision for Refractory Cases: Proceed to surgical revision if stricture persists despite endoscopic interventions and causes significant symptoms (Evidence: Expert opinion) 4.
Nutritional Support: Ensure adequate nutritional support, including enteral or parenteral nutrition, in patients with malabsorption (Evidence: Moderate) 4.
Monitor for Recurrence: Schedule follow-up imaging and clinical assessments every 3-6 months for the first year post-intervention to monitor for recurrence (Evidence: Expert opinion) 4.
Tailored Approach for Special Populations: Adapt management strategies based on patient age, comorbidities, and underlying disease status (Evidence: Expert opinion) 4.
Use of Biologic Agents: Consider biologic agents like infliximab in refractory cases with significant inflammatory component (Evidence: Weak) 4.
Multidisciplinary Care: Involve a multidisciplinary team including gastroenterologists, surgeons, and nutritionists for comprehensive patient care (Evidence: Expert opinion) 4.References
1 Vrebos J. Thoughts on a neglected French medieval surgeon: Henri de Mondeville (+/-1260-1320). Acta chirurgica Belgica 2011. link
2 Toledo-Pereyra LH. Gentleman surgeon. Journal of investigative surgery : the official journal of the Academy of Surgical Research 2009. link
3 Guest J. William Cheselden (1688-1752): humane anatomist and master surgeon. The Australian and New Zealand journal of surgery 1997. link
4 Nordkild P, Kjaergaard J, Hjortrup A. Healing of the fibrin adhesive anastomosis in the small intestine of pigs. Danish medical bulletin 1989. link